Prelude Therapeutics Incorporated

PRLD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$12,474$25,291$30,605$31,828
Short-Term Investments$121,140$207,644$171,123$259,405
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,281$2,654$2,652$3,882
Total Curr. Assets$135,895$235,589$204,380$295,115
Property Plant & Equip (Net)$35,466$37,737$6,700$5,636
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,154$4,339$9,420$4,347
Total NC Assets$39,620$42,076$16,120$9,983
Other Assets$0$0$0$0
Total Assets$175,515$277,665$220,500$305,098
Liabilities
Payables$7,732$4,580$6,777$7,840
Short-Term Debt$2,700$1,481$1,832$1,740
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$15,209$15,768$13,093$9,621
Total Curr. Liab.$25,641$21,829$21,702$19,201
LT Debt$15,325$15,407$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,090$3,339$3,361$0
Total NC Liab.$18,415$18,746$3,361$0
Other Liabilities$0$0$0$0
Cap. Leases$18,025$16,888$1,832$1,740
Total Liabilities$44,056$40,575$25,063$19,201
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$5
Retained Earnings-$583,563-$456,390-$334,558-$219,120
AOCI$35$223-$1,692-$711
Other Equity$714,982$693,252$531,682$505,723
Total Equity$131,459$237,090$195,437$285,897
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$175,515$277,665$220,500$305,098
Net Debt$5,551-$8,403-$28,773-$30,088
Prelude Therapeutics Incorporated (PRLD) Financial Statements & Key Stats | AlphaPilot